Travotis (Travoprost 0.004%) increases aqueous outflow and lowers intraocular pressure by 25–32% with a convenient once-daily dosage.
It is a first-line therapy for ocular hypertension and open-angle glaucoma.
Key Highlights
- Lowers IOP by 25–32%
- Increases aqueous outflow
- Once-daily dosage
Indications
Ocular hypertensionOpen-angle glaucoma
The product information on this website is intended for healthcare professionals and is provided for general information only. It does not replace the Instructions for Use (IFU) supplied with each product, which contain the complete indications, contraindications, warnings, and precautions. Always read and follow the current IFU before use. Product availability and regulatory status vary by country; please contact Oculentis Medical for information specific to your market.
